CD-4/CD-8/CD-3 with History Test at Chughtai Lab

CD-4/CD-8/CD-3 with History at Chughtai Lab

The CD-4/CD-8/CD-3 with History panel at Chughtai Lab is a highly specialized flow cytometry-based blood test designed to evaluate the quantitative and qualitative status of a patient’s cell-mediated immune system. This diagnostic assay measures the absolute counts and relative percentages of major T-lymphocyte subpopulations in peripheral blood: CD3+ (total mature T-lymphocytes), CD4+ (helper/inducer T-lymphocytes), and CD8+ (cytotoxic/suppressor T-lymphocytes). By analyzing these specific cellular markers, clinical immunologists and infectious disease specialists can gain critical insights into a patient’s immune competence, monitor the progression of human immunodeficiency virus (HIV) infection, assess primary or secondary immunodeficiency disorders, and evaluate patient responses to immunosuppressive or antiretroviral therapies.

Flow cytometry operates by passing single cells in a fluid suspension through a focused laser beam. As each cell intersects the light path, it scatters the light, and fluorescently labeled monoclonal antibodies bound to specific cell-surface antigens (CD3, CD4, and CD8) are excited, emitting light at specific wavelengths. These signals are captured and translated by sensitive detectors into digital data, allowing for the precise identification and quantification of distinct cell populations. The “with History” component of this test is of paramount clinical importance; it requires the documentation of the patient’s clinical background, current medications, and previous diagnostic results. This contextual information allows the consulting pathologist at Chughtai Lab to provide a highly personalized, clinically relevant interpretation of the flow cytometry data, distinguishing between transient immune fluctuations and chronic immunopathological states.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the utmost accuracy and reproducibility of the CD-4/CD-8/CD-3 with History test results, patients must adhere to the following preparation guidelines:

• No Fasting Required: Fasting is not mandatory for this blood test. Patients may consume food and water normally prior to sample collection.
• Medication Documentation: Inform the healthcare provider and the Chughtai Lab phlebotomist of all current medications, particularly corticosteroids, immunosuppressants, chemotherapy agents, and antiretroviral therapy (ART), as these can significantly alter T-lymphocyte counts.
• Clinical History Submission: Provide a detailed clinical history, including any known immunodeficiency diagnoses, recent viral infections, vaccination history, and previous T-cell subset reports.
• Diurnal Variation Consideration: T-lymphocyte levels exhibit natural diurnal variation, typically peaking in the evening and reaching their lowest levels in the morning. If this test is being performed sequentially to monitor a chronic condition, samples should ideally be collected at the same time of day for each subsequent evaluation.
• Avoid Strenuous Exercise: Refrain from vigorous physical activity or extreme exertion for at least 24 hours prior to the test, as acute physical stress can transiently redistribute lymphocyte populations in the bloodstream.

During the Procedure

The sample collection process is a standard venipuncture carried out by trained phlebotomists at Chughtai Lab, adhering to strict aseptic techniques and safety protocols:

• Patient Identification and Verification: The phlebotomist will verify the patient’s identity using multiple identifiers and review the clinical history form accompanying the test requisition.
• Anatomical Site Selection: The patient is seated comfortably, and an appropriate vein, typically the median cubital vein in the antecubital fossa of the arm, is selected.
• Aseptic Preparation: A tourniquet is applied briefly above the selected site to engorge the vein, and the skin is thoroughly cleansed with an antiseptic swab (70% isopropyl alcohol) and allowed to air dry.
• Venipuncture: A sterile, single-use needle is inserted into the vein, and blood is drawn directly into an evacuated collection tube containing Ethylenediaminetetraacetic acid (EDTA) as an anticoagulant. EDTA is critical for preserving cell morphology and surface antigen integrity.
• Post-Collection Care: Once the required volume of blood is collected, the needle is gently withdrawn, and immediate pressure is applied to the puncture site with a sterile gauze pad to prevent hematoma formation. A protective adhesive bandage is then applied.
• Sample Handling: The tube is gently inverted 8 to 10 times to ensure thorough mixing of the blood with the anticoagulant. It is immediately labeled with the patient’s unique barcode and kept at room temperature (never frozen or exposed to extreme heat) to maintain cell viability during transport to the flow cytometry laboratory.

When is a CD-4/CD-8/CD-3 with History Performed?

Monitoring HIV Infection and AIDS Progression

In patients diagnosed with Human Immunodeficiency Virus (HIV), the virus selectively targets and destroys CD4+ T-lymphocytes. This test is performed routinely to establish baseline immune status, monitor the rate of immunological decline, and determine the clinical stage of HIV infection. It is the primary laboratory tool used to assess the risk of developing opportunistic infections, with a CD4 count below 200 cells/µL defining the transition to Acquired Immunodeficiency Syndrome (AIDS). Furthermore, the test is essential for evaluating the efficacy of Antiretroviral Therapy (ART), where a successful response is indicated by a progressive rise in CD4+ T-cell counts and a normalization of the CD4/CD8 ratio.

Evaluation of Primary and Secondary Immunodeficiencies

Physicians request this comprehensive panel when evaluating patients suspected of having primary (congenital) or secondary (acquired) immunodeficiency disorders. Clinical indicators include recurrent, severe, or atypical infections, such as persistent oral candidiasis, recurrent pneumonias, or opportunistic fungal infections. By quantifying CD3+, CD4+, and CD8+ populations, immunologists can diagnose specific cellular immunodeficiencies, such as Severe Combined Immunodeficiency (SCID) in infants, Common Variable Immunodeficiency (CVID), or immunodeficiencies secondary to malnutrition, chronic diseases, or medical interventions.

Monitoring Post-Transplant Immunosuppressive Therapy

Patients who have undergone solid organ transplantation or hematopoietic stem cell transplantation require lifelong or long-term immunosuppressive therapy to prevent graft rejection or graft-versus-host disease (GVHD). This panel is utilized to monitor the degree of T-cell suppression induced by medications such as cyclosporine, tacrolimus, or monoclonal antibodies. Maintaining T-lymphocyte subsets within a specific therapeutic window is crucial to prevent organ rejection while minimizing the risk of life-threatening opportunistic infections and drug-induced toxicities.

Assessment of Autoimmune and Chronic Inflammatory Disorders

T-lymphocytes play a central role in the pathogenesis of various autoimmune diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis, and multiple sclerosis. Alterations in the balance between helper T-cells (CD4+) and cytotoxic/suppressor T-cells (CD8+) can reflect systemic immune dysregulation. Clinicians utilize this panel, along with the patient’s clinical history, to assess the immunological activity of autoimmune diseases, monitor disease flares, and evaluate the immunomodulatory effects of biologic therapies.

Investigating Unexplained Lymphopenia or Chronic Infections

When routine complete blood counts (CBC) reveal persistent, unexplained lymphopenia (low absolute lymphocyte count), this flow cytometry panel is indicated to identify which specific lymphocyte subset is depleted. It is also highly valuable in investigating patients suffering from chronic, unresolved viral infections (such as Epstein-Barr Virus, Cytomegalovirus, or chronic Hepatitis B and C), where T-cell exhaustion or atypical clonal expansions of CD8+ T-cells may be occurring, helping to guide targeted therapeutic strategies.

What Does a CD-4/CD-8/CD-3 with History Detect?

The CD-4/CD-8/CD-3 with History panel at Chughtai Lab detects a wide spectrum of immunological states and cellular abnormalities, including:

• Normal Immune Competence: Absolute counts and percentages of CD3+, CD4+, and CD8+ cells within established, age-specific reference ranges.
• Severe T-Cell Lymphopenia: A profound reduction in absolute CD3+ T-cells, indicating a generalized compromise of the cellular immune system.
• T-Cell Lymphocytosis: An abnormal elevation in absolute CD3+ T-cells, often associated with acute viral infections or lymphoproliferative disorders.
• Immunological AIDS: An absolute CD4+ T-lymphocyte count of less than 200 cells/µL in HIV-positive patients, indicating severe immunodeficiency.
• High Risk for Opportunistic Infections: CD4+ counts below 200 cells/µL (high risk for Pneumocystis jirovecii pneumonia) or below 50 cells/µL (extreme risk for Cytomegalovirus and Mycobacterium avium complex).
• Mild-to-Moderate CD4 Depletion: CD4+ counts between 200 and 499 cells/µL, indicating moderate immune impairment.
• Inverted CD4/CD8 Ratio: A ratio of less than 1.0, which is a classic hallmark of progressive HIV infection, chronic viral infections, or senescent immune systems.
• CD8+ Cytotoxic T-Cell Expansion: An elevated absolute CD8+ count, commonly observed during the acute phase of viral infections like infectious mononucleosis (EBV) or CMV.
• CD8+ T-Cell Depletion: A abnormally low CD8+ count, which can be seen in certain congenital immunodeficiencies or selective drug therapies.
• Immune Reconstitution Inflammatory Syndrome (IRIS) Patterns: Rapidly rising CD4+ counts and percentages following the initiation of effective antiretroviral therapy.
• Persistent Immunologic Non-Response: Failure of CD4+ T-cells to increase significantly despite successful viral suppression on ART.
• Drug-Induced Immunosuppression: Marked reductions in CD3+, CD4+, and CD8+ populations secondary to chemotherapy, radiation, or systemic corticosteroid therapy.
• Congenital Cellular Immunodeficiencies: Distinct absence or severe depletion of specific T-cell subsets in pediatric patients, suggestive of SCID or DiGeorge syndrome.
• Th1/Th2 Balance Shifts: Indirect indications of immune polarization based on clinical history and subset ratios.
• Senescent Immune Profile: Characterized by a low CD4/CD8 ratio, decreased naive T-cell populations, and expanded memory T-cell populations in elderly patients.
• Atypical Lymphoproliferative Clones: Abnormal light scatter properties or aberrant co-expression of markers indicating potential T-cell malignancies.
• Selective CD4+ Helper T-Cell Loss: Isolated depletion of CD4+ cells with spared CD8+ populations, pointing toward specific viral or autoimmune etiologies.
• Transient Stress-Induced Lymphopenia: Temporary decreases in circulating T-cells due to acute physiological trauma, surgery, or severe psychological stress.
• Chronic Inflammatory State: Persistent, low-grade elevations in CD8+ T-cells and altered activation markers correlated with chronic infections.
• Response to Immunomodulatory Therapy: Stabilization or normalization of T-cell subsets in patients undergoing treatment for autoimmune diseases.
• Graft-versus-Host Disease Risk: Specific T-cell subset imbalances in post-transplant patients that correlate with an increased risk of GVHD.
• Post-Viral Recovery Phase: Gradual return of expanded CD8+ populations to baseline levels following the resolution of an acute viral illness.

Turnaround Time and Report Access at Chughtai Lab

Chughtai Lab is committed to delivering highly accurate diagnostic results with optimal efficiency. Because flow cytometry is a complex, multi-step cellular analysis requiring expert interpretation, the turnaround time for the CD-4/CD-8/CD-3 with History test is typically 24 to 48 hours from the time of sample collection. Once the analysis is completed and verified by a consultant pathologist, patients and their referring physicians can access the comprehensive report digitally. Reports can be downloaded directly from the official Chughtai Lab website (myreport.chughtailab.com) or through the Chughtai Lab Mobile App. Additionally, patients can opt to receive their reports via WhatsApp or collect a printed copy from any of Chughtai Lab’s numerous collection centers located across Pakistan.

CD-4/CD-8/CD-3 with History Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Absolute CD3+ Count (Total T-Cells)	600 – 3,100 cells/µL	< 600 cells/µL (T-cell lymphopenia); > 3,100 cells/µL (T-cell lymphocytosis/viral infection)
Absolute CD4+ Count (Helper T-Cells)	410 – 1,590 cells/µL	< 200 cells/µL (Severe immunodeficiency/AIDS); < 500 cells/µL (Moderate immunodeficiency)
Absolute CD8+ Count (Cytotoxic T-Cells)	190 – 1,140 cells/µL	> 1,140 cells/µL (Acute viral infection/EBV/CMV); < 190 cells/µL (Selective immunodeficiency)
CD4/CD8 Ratio	1.0 – 2.5	< 1.0 (Inverted ratio, typical of HIV/AIDS or active viral infections); > 2.5 (Autoimmune activity)
CD3+ Percentage	55% – 85% of total lymphocytes	< 55% (Generalized T-cell depletion); > 85% (T-cell lymphoproliferative disorders)
CD4+ Percentage	31% – 54% of total lymphocytes	< 31% (Selective helper T-cell loss, common in HIV progression)
CD8+ Percentage	12% – 35% of total lymphocytes	> 35% (Active cytotoxic response to viral pathogens or chronic inflammation)
Clinical History Correlation	No significant immunopathological history	Documented history of HIV, opportunistic infections, or immunosuppressant use correlating with cell depletion

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for CD-4/CD-8/CD-3 with History?

• Advanced Flow Cytometry Department: Chughtai Lab utilizes state-of-the-art flow cytometers capable of multi-color analysis for highly precise cellular quantification.
• Expert Pathologists: All cellular immunology reports are reviewed and interpreted by experienced consultant hematopathologists and clinical immunologists.
• Strict Quality Assurance: The laboratory adheres to rigorous internal quality control protocols and participates in international external quality assessment programs.
• Comprehensive History Integration: Chughtai Lab meticulously documents and integrates patient clinical history to provide context-specific diagnostic interpretations.
• Nationwide Accessibility: With a vast network of collection centers across Pakistan, patients can easily access this specialized test in Lahore, Karachi, Islamabad, and other cities.
• Convenient Home Sample Collection: Professional, trained phlebotomists are available to collect blood samples in the comfort of the patient’s home, maintaining sample integrity during transport.
• Rapid and Secure Digital Reports: Patients can access their reports securely online, via the Chughtai Lab mobile app, or directly through WhatsApp.
• Patient-Centric Care: Chughtai Lab is dedicated to providing a compassionate, comfortable, and professional environment for all patients undergoing diagnostic testing.